Company profile: ZenBio
1.1 - Company Overview
Company description
- Provider of human cell-based research products and contract research services, including preadipocytes and adipocytes for drug screening and development; cell-based assay development and custom consultations; individualized cell-based or biochemical screening programs; cell characterization and molecular biology services; and ready-to-use visceral preadipocyte and adipocyte media.
Products and services
- Cell-Based Assay Development: ZenBio architects custom-engineered cell-based assays and delivers specialized consultations to support research and testing in human cell-based studies
- Human Cell-Based Products: ZenBio supplies research-grade human preadipocytes and adipocytes for drug screening and development, delivering physiologically relevant cell components for human cell-based research applications
- Contract Research Services: ZenBio delivers custom-tailored contract research services for outsourcing key projects, including assay development and custom consultations, supporting human cell-based research and testing
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ZenBio
Q1 Scientific
HQ: Ireland
Website
- Description: Provider of environmentally controlled stability storage services for the pharmaceutical, medical device and life sciences industries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Q1 Scientific company profile →
Impopharma
HQ: Canada
Website
- Description: Provider of comprehensive drug product formulation and process development, along with wide-ranging analytical testing services for the pharmaceutical industry, specializing in nasal and pulmonary drug products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Impopharma company profile →
Ventus Therapeutics
HQ: United States
Website
- Description: Provider of novel small molecule medicines targeting the innate immune system to treat autoimmune and inflammatory diseases and cancer. Offers VENT-03, a first-in-class oral cGAS inhibitor in Phase 1; VENT-02, a brain-penetrant NLRP3 inhibitor in Phase 1 for neuro-inflammation and neurodegeneration; and ReSOLVE, a structural biology and computational chemistry platform for small molecule drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ventus Therapeutics company profile →
Legacy Packaging
HQ: United States
Website
- Description: Provider of pharmaceutical packaging services including bottle filling (30cc–1500cc), blister packaging (thermoform and coldform), and unit-of-use bottling under its own or client NDC codes with rebate management. Offers Ecoslide compliance packaging (senior-friendly, child-resistant), secondary packaging (cartoning, clamshell/blistershell filling, display assembly, inspection), and inline/offline serialization solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Legacy Packaging company profile →
IDEA Pharma
HQ: United States
Website
- Description: Provider of strategic marketing, portfolio and disease area strategy, positioning, scenario planning and communication strategy for pharmaceutical companies, including path-to-market strategies addressing clinical, regulatory and commercial challenges; innovation strategy; strategic pharmaceutical positioning; Immersion, Design, Evaluation, Acceleration insights; and the annual Pharmaceutical Innovation and Invention Index.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEA Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ZenBio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ZenBio
2.2 - Growth funds investing in similar companies to ZenBio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ZenBio
4.2 - Public trading comparable groups for ZenBio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →